Table 2. Cox proportional analysis for the prediction of CRPC progression-free survival.
Covariant | HR | 95% CI | P-value |
---|---|---|---|
miR-27b | 0.255 | 0.069-0.944 | 0.0407 |
Gleason score | 2.003 | 0.747-5.374 | 0.1674 |
cT stage | 2.111 | 0.490-9.098 | 0.3162 |
cN stage | 2.28 | 0.372-13.975 | 0.3729 |
cM stage | 1.021 | 0.203-5.124 | 0.9799 |
PSA | 1.001 | 1.000-1.001 | 0.0719 |
Age | 1.045 | 0.949-1.150 | 0.3674 |